Cipla, leading drug maker witnessed a rise in share prices on Monday after it announced that the company aims to build a strong presence in Kenya. In line with it's global strategy, Cipla continues to retain ownership of its marketing authorisations and trademarks for its products in Kenya and will continue to invest further in developing the Kenya market.
Shares of the company are trading at Rs 616.05, up Rs 4.55, or 0.74% at the Bombay Stock Exchange (BSE) on Monday at 1:23 p.m.
The scrip has touched an intra-day high of Rs 621 and low of Rs 608.30. The total volume of shares traded at the BSE is 99,660.